Publication | Closed Access

Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties

Psychoactive DrugPsychiatryDrug DesignMedicinePsychotropic MedicationRational Drug DesignPsychopharmacologyPotential Antidepressant PropertiesLead IdentificationStructure-based DesignBiological PsychiatryPharmacologyDrug Discovery